Researchers at the University of Iowa in the US have used a mutation in the tumour suppressor p53 as a sort of “Achilles heel” to be able to attack endometrial cancer with nanoparticles loaded with anti-cancer drugs. The breakthrough therapeutic technique, which should work for other types of cancers too, might be readily translated to the clinic………
http://nanotechweb.org/cws/article/tech/70653
